Skip to Content
PR Newswire

FLOWERS FOODS, INC. REPORTS SECOND QUARTER 2022 RESULTS

FLOWERS FOODS, INC. REPORTS SECOND QUARTER 2022 RESULTS

FLOWERS FOODS, INC. REPORTS SECOND QUARTER 2022 RESULTS

PR Newswire

THOMASVILLE, Ga., Aug. 11, 2022

THOMASVILLE, Ga., Aug. 11, 2022 /PRNewswire/ -- Flowers Foods, Inc. (NYSE: FLO), producer of Nature's Own, Dave's Killer Bread, Wonder, Canyon Bakehouse, Tastykake, and other bakery foods, today reported financial results for the company's 12-week second quarter ended July 16, 2022.

Compared to the prior year second quarter where applicable

  • Sales increased 11.0% to $1.129 billion.
  • Net income decreased 4.8% to $53.7 million. Adjusted net income decreased 5.2% to $65.2 million.
  • Adjusted EBITDA(1) decreased 1.8% to $120.0 million, representing 10.6% of sales, a 140-basis point decrease.
  • Diluted EPS decreased $0.01 to $0.25. Adjusted diluted EPS(1) decreased $0.01 to $0.31.

"I am very pleased with our record second quarter sales results, an achievement that reflects the strength of our leading brands and outstanding commitment of our dedicated Flowers team," said Ryals McMullian, president and CEO of Flowers Foods. "Our performance in this challenging consumer environment demonstrates the resiliency of the category and underscores the advantages of our diversified business model. As more consumers seek to maximize the value of their spending, our diverse product line and broad distribution enables us to satisfy consumer demand at various price points wherever they shop.

"The successful execution of our pricing and portfolio strategies, together with our diligent focus on efficiencies, mitigated many of the inflationary and supply chain pressures and drove better-than-expected margins. Reflecting this strong performance, we are increasing the bottom of our earnings outlook range. To further enhance shareholder value, we increased our dividend, repurchased shares, and invested in Base Culture, a fast-growing, premium baked goods brand. As always, we remain committed to executing on our strategic pillars and driving results in line with our long-term financial targets."

  • Sales in the range of approximately $4.764 billion to $4.850 billion, representing an increase of approximately 10.0% to 12.0% compared to the prior year period.
  • Adjusted EPS(1) in the range of approximately $1.25 to $1.30, compared to prior guidance of $1.20 to $1.30.

The company's outlook is based on the following assumptions:

  • Depreciation and amortization in the range of $135 million to $145 million
  • Net interest expense of approximately $7 million
  • An effective tax rate in the range of 24.0% to 24.5%
  • Weighted average diluted share count for the year of approximately 213.5 million shares
  • Capital expenditures in the range of $150 million to $160 million, with $60 million to $70 million related to the ERP upgrade

(1) Adjusted for items affecting comparability. See reconciliations of non-GAAP measures in the financial statements following this release.

 




For the 12-Week Period
Ended



For the 12-Week Period
Ended




July 16, 2022



July 17, 2021


Net income per diluted common share


$

0.25



$

0.26


Business process improvement consulting costs



0.04




0.05


Severance and lease terminations



0.01





Legal settlement



0.01





Acquisition consideration adjustment






0.01


Adjusted net income per diluted common share


$

0.31



$

0.32



Certain amounts may not add due to rounding.


Compared to the prior year second quarter where applicable

  • Sales increased 11.0% to a second quarter record, $1.129 billion, surpassing the previous record second quarter results in 2020 that were influenced by the pandemic.
  • Percentage point change in sales attributed to:
    • Pricing/mix: 14.4%
    • Volume: -3.4%
  • Branded retail sales increased $61.4 million or 9.1% to $735.9 million, store branded retail sales increased $26.2 million or 20.0% to $157.2 million, while non-retail and other sales increased $24.2 million or 11.4% to $235.9 million.
  • Branded retail sales increased due to higher prices intended to offset inflationary pressures, partially offset by volume declines and sales mix reversion.
  • Store branded retail sales increased primarily due to higher prices intended to offset inflationary pressures. Volumes were relatively flat as positive growth from sales mix shifts was offset by targeted sales rationalization and packaging shortages.
  • Non-retail and other sales increased primarily due to higher prices intended to offset inflationary pressures, partially offset by volume declines in fast food and co-manufactured items.
  • Materials, supplies, labor, and other production costs (exclusive of depreciation and amortization) were 51.9% of sales, a 240-basis point increase. These costs increased as a percentage of sales due to higher ingredient and packaging costs, partly offset by higher sales that leveraged labor expenses, and timing differences in the sell-through of product inventories.
  • Selling, distribution and administrative (SD&A) expenses were 38.8% of sales, a 130-basis point decrease, benefitting from price increases and lower labor and marketing expenses, and distributor distribution fees, partially offset by higher logistics expenses. Excluding matters affecting comparability, adjusted SD&A expenses were 37.5% of sales, a 90-basis point decrease from the prior year period.
  • Depreciation and amortization (D&A) expenses were $32.9 million, or 2.9% of sales, a 20-basis point decrease.
  • Net income decreased 4.8% to $53.7 million due to all of the factors mentioned above, as well as lower interest income, and a higher tax rate. Adjusted net income decreased 5.2% to $65.2 million.
  • Adjusted EBITDA decreased 1.8% to $120.0 million, representing 10.6% of sales, a 140-basis point decrease.

Year-to-date, through the end of the second quarter of fiscal 2022, cash flow from operating activities decreased by $39.6 million to $183.8 million, capital expenditures increased $39.6 million to $97.9 million, and dividends paid to shareholders increased $6.4 million to $93.4 million. Cash and cash equivalents were $162.5 million at the end of the second quarter of fiscal 2022.

During the second quarter of fiscal 2022, the Board of Directors increased the company's share repurchase authorization by 20.0 million shares. Year-to-date the company repurchased $16.5 million of common stock, including $6.5 million in the second quarter, leaving 25.1 million shares remaining for repurchase under the company's current share repurchase plan. The company expects to continue to execute share repurchases from time to time under this plan.

In conjunction with this release, pre-recorded management remarks and a supporting slide presentation will be posted to the Flowers Foods website. The company will host a live question and answer webcast at 8:30 a.m. (Eastern) on August 12, 2022. The pre-recorded remarks and the webcast can be accessed at flowersfoods.com/investors, where it will be archived.

Headquartered in Thomasville, Ga., Flowers Foods, Inc. (NYSE: FLO) is one of the largest producers of packaged bakery foods in the United States with 2021 sales of $4.3 billion. Flowers operates bakeries across the country that produce a wide range of bakery products. Among the company's top brands are Nature's Own, Dave's Killer Bread, Wonder, Canyon Bakehouse, and Tastykake. Learn more at www.flowersfoods.com.

 FLO-IR   FLO-CORP

Statements contained in this filing and certain other written or oral statements made from time to time by Flowers Foods, Inc. (the "company", "Flowers Foods", "Flowers", "us", "we", or "our") and its representatives that are not historical facts are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to current expectations regarding our future financial condition and results of operations and the ultimate impact of the novel strain of coronavirus ("COVID-19") on our business, results of operations and financial condition and are often identified by the use of words and phrases such as "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "predict," "project," "should," "will," "would," "is likely to," "is expected to" or "will continue," or the negative of these terms or other comparable terminology. These forward-looking statements are based upon assumptions we believe are reasonable. Forward-looking statements are based on current information and are subject to risks and uncertainties that could cause our actual results to differ materially from those projected. Certain factors that may cause actual results, performance, liquidity, and achievements to differ materially from those projected are discussed in our Annual Report on Form 10-K (the "Form 10-K") and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission ("SEC') and may include, but are not limited to, (a) unexpected changes in any of the following: (1) general economic and business conditions; (2) the competitive setting in which we operate, including advertising or promotional strategies by us or our competitors, as well as changes in consumer demand; (3) interest rates and other terms available to us on our borrowings; (4) supply chain conditions and any related impact on energy and raw materials costs and availability and hedging counter-party risks; (5) relationships with or increased costs related to our employees and third-party service providers; (6) laws and regulations (including environmental and health-related issues); and (7) accounting standards or tax rates in the markets in which we operate, (b) the ultimate impact of the COVID-19 pandemic and future responses and/or measures taken in response thereto, including, but not limited to, new and emerging variants of the virus and the efficacy and distribution of vaccines, which are highly uncertain and are difficult to predict, (c) the loss or financial instability of any significant customer(s), including as a result of product recalls or safety concerns related to our products, (d) changes in consumer behavior, trends and preferences, including health and whole grain trends, and the movement toward more inexpensive store branded products, (e) the level of success we achieve in developing and introducing new products and entering new markets, (f) our ability to implement new technology and customer requirements as required, (g) our ability to operate existing, and any new, manufacturing lines according to schedule, (h) our ability to implement and achieve our environmental, social, and governance ("ESG") goals in accordance with suppliers, regulations, and customers; (i) our ability to execute our business strategies which may involve, among other things, (1) the ability to realize the intended benefits of planned or contemplated acquisitions, dispositions or joint ventures, (2) the deployment of new systems (e.g., our enterprise resource planning ("ERP") system), distribution channels and technology, and (3) an enhanced organizational structure, (j) consolidation within the baking industry and related industries, (k) changes in pricing, customer and consumer reaction to pricing actions (including decreased volumes), and the pricing environment among competitors within the industry, (l) our ability to adjust pricing to offset, or partially offset, inflationary pressure on the cost of our products; (m) disruptions in our direct-store-delivery distribution model, including litigation or an adverse ruling by a court or regulatory or governmental body, or other regulatory developments, that could affect the independent contractor classifications of the independent distributor partners, (n) increasing legal complexity and legal proceedings that we are or may become subject to, (o) labor shortages and turnover or increases in employee and employee-related costs, (p) the credit, business, and legal risks associated with independent distributor partners and customers, which operate in the highly competitive retail food and foodservice industries, (q) any business disruptions due to political instability, pandemics, armed hostilities (including the ongoing conflict between Russia and Ukraine), incidents of terrorism, natural disasters, labor strikes or work stoppages, technological breakdowns, product contamination, product recalls or safety concerns related to our products, or the responses to or repercussions from any of these or similar events or conditions and our ability to insure against such events, (r) the failure of our information technology ("IT") systems to perform adequately, including any interruptions, intrusions, cyber-attacks or security breaches of such systems or risks associated with the planned implementation of the upgrade of our ERP system; and (s) the potential impact of climate change on the company, including physical and transition risks, higher regulatory and compliance costs, reputational risks, and availability of capital on attractive terms. The foregoing list of important factors does not include all such factors, nor necessarily present them in order of importance. In addition, you should consult other disclosures made by the company (such as in our other filings with the SEC or in company press releases) for other factors that may cause actual results to differ materially from those projected by the company. Refer to Part I, Item 1A., Risk Factors, of the Form 10-K, Part II, Item 1A., Risk Factors of the Form 10-Q for the quarter ended July 16, 2022 and subsequent filing with the SEC for additional information regarding factors that could affect the company's results of operations, financial condition and liquidity. We caution you not to place undue reliance on forward-looking statements, as they speak only as of the date made and are inherently uncertain. The company undertakes no obligation to publicly revise or update such statements, except as required by law. You are advised, however, to consult any further public disclosures by the company (such as in our filings with the SEC or in company press releases) on related subjects.

The company prepares its consolidated financial statements in accordance with U.S. Generally Accepted Accounting Principles (GAAP). However, from time to time, the company may present in its public statements, press releases and SEC filings, non-GAAP financial measures such as, EBITDA, adjusted EBITDA, EBITDA margin, adjusted EBITDA margin, adjusted net income, adjusted EPS, adjusted income tax expense, adjusted selling, distribution and administrative expenses (SD&A), gross margin excluding depreciation and amortization, free cash flow, and the ratio of net debt to adjusted EBITDA. The reconciliations attached provide reconciliations of the non-GAAP measures used in this presentation or release to the most comparable GAAP financial measure. The company's definitions of these non-GAAP measures may differ from similarly titled measures used by others. These non-GAAP measures should be considered supplemental to, and not a substitute for, financial information prepared in accordance with GAAP.

The company defines EBITDA as earnings before interest, taxes, depreciation and amortization. Earnings are net income. The company believes that EBITDA is a useful tool for managing the operations of its business and is an indicator of the company's ability to incur and service indebtedness and generate free cash flow. EBITDA is used as the primary performance measure in the company's 2014 Omnibus Equity and Incentive Compensation Plan. Furthermore, pursuant to the terms of our credit facility, EBITDA is used to determine the company's compliance with certain financial covenants. The company also believes that EBITDA measures are commonly reported and widely used by investors and other interested parties as measures of a company's operating performance and debt servicing ability because EBITDA measures assist in comparing performance on a consistent basis without regard to depreciation or amortization, which can vary significantly depending upon accounting methods and non-operating factors (such as historical cost). EBITDA is also a widely-accepted financial indicator of a company's ability to incur and service indebtedness.

EBITDA should not be considered an alternative to (a) income from operations or net income (loss) as a measure of operating performance; (b) cash flows provided by operating, investing and financing activities (as determined in accordance with GAAP) as a measure of the company's ability to meet its cash needs; or (c) any other indicator of performance or liquidity that has been determined in accordance with GAAP.

The company defines adjusted EBITDA, EBITDA margin, adjusted EBITDA margin, adjusted net income, adjusted diluted EPS, adjusted income tax expense and adjusted SD&A, respectively, excluding the impact of asset impairment charges, Project Centennial consulting costs, business process improvement costs, lease terminations, legal settlements, acquisition-related costs, and pension plan settlements. The company believes that these measures, when considered together with its GAAP financial results, provides management and investors with a more complete understanding of its business operating results, including underlying trends, by excluding the effects of certain charges.

The company defines free cash flow as operating cash flow minus capital expenditures. The company believes that free cash flow provides investors a better understanding of the company's liquidity position. The company defines net debt as total debt less cash and cash equivalents. Net debt to EBITDA is used as a measure of financial leverage employed by the company. Gross margin excluding depreciation and amortization is used as a performance measure to provide additional transparent information regarding our results of operations on a consolidated and segment basis. Changes in depreciation and amortization are separately discussed and include depreciation and amortization for materials, supplies, labor and other production costs and operating activities.

Presentation of gross margin includes depreciation and amortization in the materials, supplies, labor and other production costs according to GAAP. Our method of presenting gross margin excludes the depreciation and amortization components, as discussed above.

The reconciliations attached provide reconciliations of the non-GAAP measures used in this presentation or release to the most comparable GAAP financial measure.

Flowers Foods, Inc. 

Condensed Consolidated Balance Sheets

(000's omitted)




July 16, 2022



January 1, 2022








Cash and cash equivalents


$

162,511



$

185,871


Other current assets



637,861




531,154


Property, plant and equipment, net



829,531




798,728


Right-of-use leases, net



282,946




292,489


Distributor notes receivable (1)



171,403




183,403


Other assets



32,231




20,992


Cost in excess of net tangible assets, net



1,224,238




1,240,676


Total assets


$

3,340,721



$

3,253,313








Current liabilities


$

520,764



$

471,943


Long-term debt



891,241




890,609


Right-of-use lease liabilities (2)



292,648




300,522


Other liabilities



188,600




178,965


Stockholders' equity



1,447,468




1,411,274


Total liabilities and stockholders' equity


$

3,340,721



$

3,253,313











(1)

Includes current portion of $26,714 and $29,093, respectively.

(2)

Includes current portion of $49,397 and $47,974, respectively.

 

Flowers Foods, Inc.

Consolidated Statement of Operations

(000's omitted, except per share data)




For the 12-Week
Period Ended



For the 12-Week
Period Ended



For the 28-Week
Period Ended



For the 28-Week
Period Ended




July 16, 2022



July 17, 2021



July 16, 2022



July 17, 2021


Sales


$

1,129,051



$

1,017,309



$

2,564,983



$

2,319,477


Materials, supplies, labor and other production costs (exclusive of depreciation and amortization shown separately below)



586,084




504,062




1,310,676




1,147,638


Selling, distribution and administrative expenses



438,350




407,707




993,302




909,680


Loss on inferior ingredients












122


Impairment of assets









990





Depreciation and amortization expense



32,922




31,619




76,345




73,005


Income from operations



71,695




73,921




183,670




189,032


Other pension benefit



(178)




(93)




(416)




(218)


Loss on extinguishment of debt












16,149


Interest expense, net



1,504




1,070




3,605




5,271


Income before income taxes



70,369




72,944




180,481




167,830


Income tax expense



16,689




16,586




41,212




39,817


Net income


$

53,680



$

56,358



$

139,269



$

128,013


Net income per diluted common share


$

0.25



$

0.26



$

0.65



$

0.60


Diluted weighted average shares outstanding



213,307




213,056




213,315




212,897


 

Flowers Foods, Inc.

Condensed Consolidated Statement of Cash Flows

(000's omitted)




For the 12-Week
Period Ended



For the 12-Week
Period Ended



For the 28-Week
Period Ended



For the 28-Week
Period Ended




July 16, 2022



July 17, 2021



July 16, 2022



July 17, 2021


Cash flows from operating activities:













Net income


$

53,680



$

56,358



$

139,269



$

128,013


Adjustments to reconcile net income to net cash from operating activities:













Total non-cash adjustments



44,283




40,766




108,952




96,604


Changes in assets and liabilities



(38,284)




28,311




(64,388)




(1,187)


Net cash provided by operating activities



59,679




125,435




183,833




223,430


Cash flows from investing activities:













Purchase of property, plant and equipment



(47,365)




(30,992)




(97,862)




(58,270)


Proceeds from sale of property, plant and equipment



144




252




1,575




2,411


Investment in unconsolidated affiliate



(9,000)







(9,000)





Acquisition of trademarks






(10,200)







(10,200)


Other



5,006




3,086




12,177




9,088


Net cash disbursed for investing activities



(51,215)




(37,854)




(93,110)




(56,971)


Cash flows from financing activities:













Dividends paid



(46,700)




(44,539)




(93,447)




(87,042)


Stock repurchases



(6,465)







(16,514)




(1,058)


Net change in debt borrowings












(81,858)


Payments on financing leases



(438)




(443)




(864)




(866)


Other



2,503




(899)




(3,258)




(10,841)


Net cash disbursed for financing activities



(51,100)




(45,881)




(114,083)




(181,665)


Net increase (decrease) in cash and cash equivalents



(42,636)




41,700




(23,360)




(15,206)


Cash and cash equivalents at beginning of period



205,147




250,570




185,871




307,476


Cash and cash equivalents at end of period


$

162,511



$

292,270



$

162,511



$

292,270


 

Flowers Foods, Inc. 

Sales by Sales Class and Sales Bridge 

(000's omitted) 


Sales by Sales Class


For the 12-Week Period
Ended



For the 12-Week Period
Ended










July 16, 2022



July 17, 2021



$ Change



% Change


Branded Retail


$

735,898



$

674,489



$

61,409




9.1

%

Store Branded Retail



157,215




131,045




26,170




20.0

%

Non-Retail and Other



235,938




211,775




24,163




11.4

%

Total Sales


$

1,129,051



$

1,017,309



$

111,742




11.0

%


Sales by Sales Class


For the 28-Week Period
Ended



For the 28-Week Period
Ended










July 16, 2022



July 17, 2021



$ Change



% Change


Branded Retail


$

1,692,052



$

1,536,229



$

155,823




10.1

%

Store Branded Retail



330,819




293,522




37,297




12.7

%

Non-Retail and Other



542,112




489,726




52,386




10.7

%

Total Sales


$

2,564,983



$

2,319,477



$

245,506




10.6

%

 

Sales Bridge 


For the 12-week period ended July 16, 2022


Volume



Net
Price/Mix



Total
Sales Change


Flowers Foods



(3.4)

%



14.4

%



11.0

%














For the 28-week period ended July 16, 2022


Volume



Net
Price/Mix



Total
Sales Change


Flowers Foods



(3.3)

%



13.9

%



10.6

%














     

Flowers Foods, Inc.

Reconciliation of GAAP to Non-GAAP Measures

(000's omitted, except per share data)




Reconciliation of Earnings per Share to Adjusted Earnings per Share




For the 12-Week Period
Ended



For the 12-Week Period
Ended



For the 28-Week Period
Ended



For the 28-Week Period
Ended




July 16, 2022



July 17, 2021



July 16, 2022



July 17, 2021


Net income per diluted common share


$

0.25



$

0.26



$

0.65



$

0.60


Loss on inferior ingredients











NM


Business process improvement consulting costs



0.04




0.05




0.07




0.06


Impairment of assets








NM





Severance and lease terminations



0.01







0.01





Legal settlement



0.01







0.01





Acquisition consideration adjustment






0.01







0.01


Loss on extinguishment of debt











0.06


Adjusted net income per diluted common share


$

0.31



$

0.32



$

0.74



$

0.73


NM - not meaningful.













Certain amounts may not add due to rounding.

















Reconciliation of Gross Margin




For the 12-Week
Period Ended



For the 12-Week
Period Ended



For the 28-Week
Period Ended



For the 28-Week
Period Ended




July 16, 2022



July 17, 2021



July 16, 2022



July 17, 2021


Sales


$

1,129,051



$

1,017,309



$

2,564,983



$

2,319,477


Materials, supplies, labor and other production costs (exclusive of depreciation and amortization)



586,084




504,062




1,310,676




1,147,638


Gross Margin excluding depreciation and amortization



542,967




513,247




1,254,307




1,171,839


Less depreciation and amortization for production activities



18,167




17,814



$

41,601



$

40,944


Gross Margin


$

524,800



$

495,433



$

1,212,706



$

1,130,895


Depreciation and amortization for production activities


$

18,167



$

17,814



$

41,601



$

40,944


Depreciation and amortization for selling, distribution and administrative activities



14,755




13,805




34,744




32,061


Total depreciation and amortization


$

32,922



$

31,619



$

76,345



$

73,005






Reconciliation of Selling, Distribution and Administrative Expenses to
Adjusted SD&A




For the 12-Week Period
Ended



For the 12-Week Period
Ended



For the 28-Week Period
Ended



For the 28-Week Period
Ended




July 16, 2022



July 17, 2021



July 16, 2022



July 17, 2021


Selling, distribution and administrative expenses (SD&A)


$

438,350



$

407,707



$

993,302



$

909,680


Business process improvement costs



(11,658)




(13,205)




(20,722)




(18,163)


Severance and lease terminations



(1,717)







(1,717)





Legal settlement



(2,000)







(2,000)





Acquisition consideration adjustment






(3,400)







(3,400)


Adjusted SD&A


$

422,975



$

391,102



$

968,863



$

888,117


 

Flowers Foods, Inc.

Reconciliation of GAAP to Non-GAAP Measures

(000's omitted, except per share data)




Reconciliation of Net Income to EBITDA and Adjusted EBITDA




For the 12-Week
Period Ended



For the 12-Week
Period Ended



For the 28-Week
Period Ended



For the 28-Week
Period Ended




July 16, 2022



July 17, 2021



July 16, 2022



July 17, 2021


Net income


$

53,680



$

56,358



$

139,269



$

128,013


Income tax expense



16,689




16,586




41,212




39,817


Interest expense, net



1,504




1,070




3,605




5,271


Loss on extinguishment of debt












16,149


Depreciation and amortization



32,922




31,619




76,345




73,005


EBITDA



104,795




105,633




260,431




262,255


Other pension benefit



(178)




(93)




(416)




(218)


Loss on inferior ingredients












122


Business process improvement consulting costs



11,658




13,205




20,722




18,163


Impairment of assets









990





Severance and lease terminations



1,717







1,717





Legal settlement



2,000







2,000





Acquisition consideration adjustment






3,400







3,400


Adjusted EBITDA


$

119,992



$

122,145



$

285,444



$

283,722


Sales


$

1,129,051



$

1,017,309



$

2,564,983



$

2,319,477


Adjusted EBITDA margin



10.6

%



12.0

%



11.1

%



12.2

%





Reconciliation of Income Tax Expense to Adjusted Income Tax Expense




For the 12-Week Period
Ended



For the 12-Week Period
Ended



For the 28-Week Period
Ended



For the 28-Week Period
Ended




July 16, 2022



July 17, 2021



July 16, 2022



July 17, 2021


Income tax expense


$

16,689



$

16,586



$

41,212



$

39,817


Tax impact of:













Loss on inferior ingredients












31


Business process improvement consulting costs



2,915




3,301




5,181




4,541


Impairment of assets









248





Severance and lease terminations



429







429





Legal settlement



500







500





Acquisition consideration adjustment






850







850


Loss on extinguishment of debt












4,037


Adjusted income tax expense


$

20,533



$

20,737



$

47,570



$

49,276


 

Flowers Foods, Inc.

Reconciliation of GAAP to Non-GAAP Measures

(000's omitted, except per share data)




Reconciliation of Net Income to Adjusted Net Income




For the 12-Week Period
Ended



For the 12-Week Period
Ended



For the 28-Week Period
Ended



For the 28-Week Period
Ended




July 16, 2022



July 17, 2021



July 16, 2022



July 17, 2021


Net income


$

53,680



$

56,358



$

139,269



$

128,013


Loss on inferior ingredients












91


Business process improvement consulting costs



8,743




9,904




15,541




13,622


Impairment of assets









742





Severance and lease terminations



1,288







1,288





Legal settlement



1,500







1,500





Acquisition consideration adjustment






2,550







2,550


Loss on extinguishment of debt












12,112


Adjusted net income


$

65,211



$

68,812



$

158,340



$

156,388


 



Reconciliation of Earnings per Share -
Full Year Fiscal 2022 Guidance




Range Estimate


Net income per diluted common share


$

1.16


to

$

1.21


Business process improvement consulting costs



0.07




0.07


Impairment of assets


NM



NM


Severance and lease terminations



0.01




0.01


Legal settlement



0.01




0.01


Adjusted net income per diluted common share


$

1.25


to

$

1.30


NM - not meaningful.







 

Cision View original content:https://www.prnewswire.com/news-releases/flowers-foods-inc-reports-second-quarter-2022-results-301604633.html

SOURCE Flowers Foods, Inc.